Nu Skin Enterprises (NUS) EBITDA (2016 - 2025)
Historic EBITDA for Nu Skin Enterprises (NUS) over the last 17 years, with Q4 2025 value amounting to $23.2 million.
- Nu Skin Enterprises' EBITDA rose 14378.97% to $23.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $65.8 million, marking a year-over-year increase of 14338.36%. This contributed to the annual value of $65.8 million for FY2025, which is 14338.36% up from last year.
- Nu Skin Enterprises' EBITDA amounted to $23.2 million in Q4 2025, which was up 14378.97% from $21.6 million recorded in Q3 2025.
- In the past 5 years, Nu Skin Enterprises' EBITDA ranged from a high of $85.4 million in Q2 2021 and a low of -$125.6 million during Q2 2024
- Its 5-year average for EBITDA is $15.4 million, with a median of $21.0 million in 2021.
- Within the past 5 years, the most significant YoY rise in Nu Skin Enterprises' EBITDA was 16914.85% (2024), while the steepest drop was 43045.51% (2024).
- Quarter analysis of 5 years shows Nu Skin Enterprises' EBITDA stood at $20.3 million in 2021, then soared by 35.14% to $27.5 million in 2022, then plummeted by 41.5% to $16.1 million in 2023, then crashed by 430.46% to -$53.1 million in 2024, then surged by 143.79% to $23.2 million in 2025.
- Its last three reported values are $23.2 million in Q4 2025, $21.6 million for Q3 2025, and $30.8 million during Q2 2025.